Target intelligence / Profile preview

Fel d 1-specific CD4+ T cell receptor

Molecular classification
Receptor, T cell receptor (TCR), Immunoreceptor
01

Overview

Fel d 1-specific CD4+ T cell receptors are immunoreceptors expressed on the surface of CD4+ T lymphocytes that specifically recognize peptide antigens derived from Fel d 1—the major cat allergen—presented by MHC class II molecules. These T cell receptors initiate and regulate allergen-specific immune responses, most notably by promoting a Th2-polarized adaptive immune reaction that underlies IgE-mediated cat allergies and allergic asthma[1][2][3]. Fel d 1-specific T cells demonstrate a distinct memory Th2 molecular signature compared to T cells reactive to other antigens[3]. The assessment and manipulation of these receptors are important in the study and treatment of allergic diseases such as asthma and rhinitis triggered by cat exposure.

Other names
Allergen-specific CD4+ T cell receptor (where the allergen is Fel d 1)Cat allergen Fel d 1-specific T cell receptor
02

Mechanism of action

Recognition of Fel d 1 peptides presented by MHC class II on antigen-presenting cells, leading to CD4+ T cell activation, differentiation (primarily towards Th2 type), cytokine release, and subsequent allergic inflammation[3][2]. In allergen immunotherapy, desensitization may involve modulation of Fel d 1-specific T cell responses[3].

03

Biological functions

Immune responseAntigen recognitionInitiation of allergic inflammationMediating Th2 (and other) T cell polarization
04

Disease associations

AllergyAsthmaInflammation
05

Safety considerations

Potential for immune suppression or unwanted generalized immune modulation during allergen immunotherapy.
06

Biomarkers

Frequency or phenotype of Fel d 1-specific CD4+ T cells in blood or tissue as a biomarker for sensitization and possibly disease activity[3].

Beyond the preview

Go deeper on Fel d 1-specific CD4+ T cell receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fel d 1-specific CD4+ T cell receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call